chr3-184242588-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005787.6(ALG3):c.1243G>A(p.Val415Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000574 in 1,604,084 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_005787.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ALG3 | NM_005787.6 | c.1243G>A | p.Val415Ile | missense_variant | 9/9 | ENST00000397676.8 | |
ALG3 | NM_001006941.2 | c.1099G>A | p.Val367Ile | missense_variant | 9/9 | ||
ALG3 | NR_024533.1 | n.1174G>A | non_coding_transcript_exon_variant | 8/8 | |||
ALG3 | NR_024534.1 | n.1237G>A | non_coding_transcript_exon_variant | 9/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ALG3 | ENST00000397676.8 | c.1243G>A | p.Val415Ile | missense_variant | 9/9 | 1 | NM_005787.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152168Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000665 AC: 16AN: 240646Hom.: 0 AF XY: 0.0000536 AC XY: 7AN XY: 130564
GnomAD4 exome AF: 0.0000558 AC: 81AN: 1451916Hom.: 0 Cov.: 32 AF XY: 0.0000597 AC XY: 43AN XY: 720774
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152168Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74332
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 06, 2024 | The c.1243G>A (p.V415I) alteration is located in exon 9 (coding exon 9) of the ALG3 gene. This alteration results from a G to A substitution at nucleotide position 1243, causing the valine (V) at amino acid position 415 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
ALG3-congenital disorder of glycosylation Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 11, 2022 | This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 415 of the ALG3 protein (p.Val415Ile). This variant is present in population databases (rs375976807, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with ALG3-related conditions. ClinVar contains an entry for this variant (Variation ID: 962232). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The isoleucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at